CIBC Asset Management Inc Has $280,000 Stake in HB Fuller Co (FUL)

Share on StockTwits

CIBC Asset Management Inc lifted its holdings in shares of HB Fuller Co (NYSE:FUL) by 54.3% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 6,573 shares of the specialty chemicals company’s stock after acquiring an additional 2,314 shares during the period. CIBC Asset Management Inc’s holdings in HB Fuller were worth $280,000 as of its most recent filing with the SEC.

Several other large investors have also added to or reduced their stakes in FUL. Trust Co. of Vermont bought a new position in shares of HB Fuller during the 4th quarter worth about $26,000. Advisor Group Inc. lifted its holdings in shares of HB Fuller by 52.8% during the 4th quarter. Advisor Group Inc. now owns 1,497 shares of the specialty chemicals company’s stock worth $64,000 after acquiring an additional 517 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of HB Fuller by 16.5% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 2,643 shares of the specialty chemicals company’s stock worth $113,000 after acquiring an additional 375 shares during the period. Riverhead Capital Management LLC lifted its holdings in shares of HB Fuller by 39.1% during the 3rd quarter. Riverhead Capital Management LLC now owns 4,271 shares of the specialty chemicals company’s stock worth $221,000 after acquiring an additional 1,200 shares during the period. Finally, Quantamental Technologies LLC bought a new position in shares of HB Fuller during the 4th quarter worth about $286,000. 98.56% of the stock is owned by institutional investors.

Shares of HB Fuller stock opened at $49.68 on Monday. The stock has a market cap of $2.53 billion, a P/E ratio of 16.56, a PEG ratio of 0.79 and a beta of 1.45. The company has a quick ratio of 1.34, a current ratio of 1.99 and a debt-to-equity ratio of 1.86. HB Fuller Co has a 12-month low of $39.61 and a 12-month high of $59.58.

HB Fuller (NYSE:FUL) last announced its earnings results on Wednesday, January 16th. The specialty chemicals company reported $0.90 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.99 by ($0.09). The firm had revenue of $768.43 million for the quarter, compared to analyst estimates of $806.99 million. HB Fuller had a return on equity of 13.85% and a net margin of 5.63%. The company’s quarterly revenue was up 13.3% on a year-over-year basis. As a group, equities research analysts forecast that HB Fuller Co will post 3.3 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Thursday, February 21st. Investors of record on Thursday, February 7th were given a dividend of $0.155 per share. This represents a $0.62 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date of this dividend was Wednesday, February 6th. HB Fuller’s dividend payout ratio (DPR) is currently 20.67%.

A number of equities research analysts recently issued reports on the stock. Stifel Nicolaus assumed coverage on shares of HB Fuller in a research report on Monday, December 10th. They set a “buy” rating and a $62.00 target price for the company. ValuEngine upgraded shares of HB Fuller from a “sell” rating to a “hold” rating in a research report on Tuesday, January 22nd. Deutsche Bank cut shares of HB Fuller from a “buy” rating to a “hold” rating and set a $50.00 target price for the company. in a research report on Tuesday, February 5th. Finally, Zacks Investment Research cut shares of HB Fuller from a “hold” rating to a “sell” rating in a research report on Thursday, January 24th. One analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $59.00.

In other HB Fuller news, VP Robert J. Martsching sold 3,215 shares of the firm’s stock in a transaction dated Friday, February 15th. The shares were sold at an average price of $48.86, for a total value of $157,084.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Timothy J. Keenan sold 13,205 shares of the firm’s stock in a transaction dated Tuesday, February 12th. The shares were sold at an average price of $48.32, for a total transaction of $638,065.60. Following the completion of the sale, the vice president now owns 38,435 shares of the company’s stock, valued at approximately $1,857,179.20. The disclosure for this sale can be found here. Company insiders own 3.46% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was published by Zolmax and is the property of of Zolmax. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://zolmax.com/investing/cibc-asset-management-inc-has-280000-stake-in-hb-fuller-co-ful/2971513.html.

HB Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

Recommended Story: Yield Curve

Want to see what other hedge funds are holding FUL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HB Fuller Co (NYSE:FUL).

Institutional Ownership by Quarter for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Metropolitan Life Insurance Co. NY Grows Position in New Residential Investment Corp
Metropolitan Life Insurance Co. NY Grows Position in New Residential Investment Corp
Metropolitan Life Insurance Co. NY Has $129,000 Position in ANI Pharmaceuticals Inc
Metropolitan Life Insurance Co. NY Has $129,000 Position in ANI Pharmaceuticals Inc
Financial Analysis: VBI Vaccines  and Merck & Co., Inc.
Financial Analysis: VBI Vaccines and Merck & Co., Inc.
Analyzing Webster Financial  & Cadence Bancorp
Analyzing Webster Financial & Cadence Bancorp
Financial Analysis: CIBT Education Group  versus OneSmart International Edun Gr
Financial Analysis: CIBT Education Group versus OneSmart International Edun Gr
Metropolitan Life Insurance Co. NY Has $130,000 Stake in PC Connection, Inc.
Metropolitan Life Insurance Co. NY Has $130,000 Stake in PC Connection, Inc.


 
© 2006-2019 Zolmax.